Quidel

Quidel Receivables

The Accounts Receivable of Quidel (QDEL) as of Nov 5, 2026 is 349.50 M USD. In the previous year, Accounts Receivable was 378.00 M USD — a change of -7.54% (lower).

Receivables

349.50 MUSD

YoY

-7.54%

Last updated:

Accounts Receivable of Quidel is 2023 349.50 M USD. Accounts Receivable of Quidel was 2022 378.00 M USD. It decreases by -7.54% lower compared to the previous year.

The Quidel Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2015
18.40 M USD
Jan 1, 2016
25.00 M USD
Jan 1, 2017
67.00 M USD
Jan 1, 2018
58.70 M USD
Jan 1, 2019
94.50 M USD
Jan 1, 2020
513.70 M USD
Jan 1, 2021
378.00 M USD
Jan 1, 2023
349.50 M USD
The Quidel Receivables history
YEARReceivablesYoY
349.50 MUSD-7.54%
378.00 MUSD-26.42%
513.70 MUSD+443.60%
94.50 MUSD+60.99%
58.70 MUSD-12.39%
67.00 MUSD+168.00%
25.00 MUSD+35.87%
18.40 MUSD-46.67%
34.50 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quidel Stock analysis

What does Quidel do? Quidel Corporation is a US-based company specializing in the production of rapid tests for medical diagnostics. It was founded in 1979 and is headquartered in San Diego, California. Since 1991, it has been listed on the NASDAQ stock exchange. Quidel initially started as Diagnostic Reagents Laboratory (DRL) and focused on manufacturing diagnostic products for the veterinary sector. In 1990, it was renamed Quidel Corporation and expanded its operations into human diagnostics. The company's business model revolves around the development and production of immunological rapid tests that can quickly and easily diagnose infectious diseases and other health problems. Quidel focuses on creating high-quality, accurate, and cost-effective test procedures that can be used by healthcare professionals or even laypersons at home. One of Quidel's core competencies is bringing to market rapid tests that are easy to perform and provide immediate results without the need to send samples to a laboratory. The company offers a wide range of rapid tests for diagnosing various diseases. These include tests for infectious diseases such as influenza, streptococcus, Lyme disease, and chlamydia, as well as tests for pregnancy, drug abuse, and cardiovascular diseases. The tests are available as single tests or panel tests that can diagnose multiple diseases simultaneously. Quidel operates in four business segments: Molecular Diagnostics, Point-of-Care Diagnostics, Immunoassays, and Specialized Diagnostic Solutions. The Molecular Diagnostics segment focuses on developing molecular diagnostic tests and instruments for laboratory use. The Point-of-Care Diagnostics segment develops and produces rapid tests for use in medical practices and hospitals. The Immunoassays segment specializes in reagent-based tests for the quantitative analysis of biomolecules. The Specialized Diagnostic Solutions segment includes specialized diagnostic products, such as test systems for monitoring antibiotic therapies. In conclusion, Quidel Corporation specializes in the development and production of rapid tests for medical diagnostics. The company offers a wide range of high-quality, accurate, and cost-effective test procedures for diagnosing infectious diseases, pregnancy, drug abuse, and cardiovascular diseases. Quidel has gained a significant market share in the diagnostics field through its rapid tests and diverse range of test panels for various conditions, and it is known for its innovative products. Quidel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quidel stock

Accounts Receivable of Quidel is 349.50 M USD in 2023.

Accounts Receivable of Quidel changed from 378.00 M USD to 349.50 M USD, representing a -7.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Quidel since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Quidel historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Quidel

All Key Metrics — Quidel